報價延遲最少15分鐘:2025/05/31 20:03 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
5.68 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.09/-1.88
|
|
企業價值
515.97M
|
| 資產負債 |
|
每股賬面淨值
4.21
|
| 現金流量 |
|
現金流量率
0.22
|
| 損益表 |
|
收益
53.88M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/31 20:03 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways. |